Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SEN-12333 is an agonist of α7 nicotinic acetylcholine receptors (nAChRs; Ki = 0.26 µM).1 It is selective for α7 nAChRs over α1-, α3-, and α4β2 subunit-containing nAChRs and the serotonin (5-HT) receptor subtype 5-HT3, as well as a panel of 70 additional neurotransmitter, growth factor, and peptide receptors at 10 µM. SEN-12333 activates the α7 nAChR in GH4C1 cells expressing the rat receptor (EC50 = 1.6 µM). Topical application of SEN-12333 prevents decreases in the number of retinal ganglion cells in a rat model of glaucoma in a concentration-dependent manner.2 SEN-12333 (3 mg/kg) reverses scopolamine- or MK-801-induced memory deficits in the novel object recognition test in rats.1
WARNING This product is not for human or veterinary use.
1. SAR and biological evaluation of SEN12333/WAY-
2. Prevention of glaucoma-